Table 3.
Types of anticoagulant-type rodenticide(s) detected in the blood samples of the patients
| Total (n = 41) | Patients with exposure history (n = 31) | Patients without exposure history (n = 10) | |
|---|---|---|---|
| Anticoagulant-type rodenticide(s) detected | |||
| Bromadiolone only (n (%)) | 22 (53.7) | 18 (58.1) | 4 (40.0) |
| Bromadiolone and brodifacoum (n (%)) | 7 (17.1) | 2 (6.5) | 5 (50.0) |
| Bromadiolone and warfarin-type agents (n (%)) | 4 (9.8) | 3 (9.7) | 1 (10.0) |
| Brodifacoum only (n (%)) | 2 (4.9) | 2 (6.5) | 0 (0) |
| Flocoumafen (n (%)) | 1 (2.4) | 1 (3.2) | 0 (0) |
| Warfarin-type agents only (n (%)) | 5 (12.2) | 5 (16.1) | 0 (0) |
| Serum quantitative result (ng/mL) | |||
| Peak serum bromadiolone/brodifacoum level measured (median (IQR)) | |||
| Taken solid rat bait | – | 67 (8–154) | 337 (87–562) |
| Taken stock solution | 14,342 (3720–33,100)# | ||
#For those who had taken superwarfarin stock solution (n = 3), serum superwarfarin levels were shown as mean (range)